Molecule Holdings Inc.
EVRRF · OTC
7/31/2023 | 4/30/2023 | 1/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Revenue | $714 | $167 | $391 | $507 |
| % Growth | 328% | -57.4% | -22.7% | – |
| Cost of Goods Sold | $464 | $165 | $526 | $1,073 |
| Gross Profit | $250 | $2 | -$135 | -$567 |
| % Margin | 35% | 1.4% | -34.5% | -111.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $404 | $277 | $555 | $611 |
| SG&A Expenses | $511 | $279 | $601 | $629 |
| Sales & Mktg Exp. | $107 | $2 | $46 | $18 |
| Other Operating Expenses | $0 | $27 | $24 | $45 |
| Operating Expenses | $563 | $306 | $624 | $674 |
| Operating Income | -$313 | -$278 | -$541 | -$1,310 |
| % Margin | -43.8% | -166.6% | -138.3% | -258.7% |
| Other Income/Exp. Net | -$474 | -$369 | $78 | -$212 |
| Pre-Tax Income | -$787 | -$647 | -$681 | -$1,452 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$787 | -$881 | -$684 | -$1,474 |
| % Margin | -110.2% | -527.8% | -174.9% | -291% |
| EPS | -0.01 | -0.009 | -0.007 | -0.015 |
| % Growth | -11.1% | -28.6% | 53.6% | – |
| EPS Diluted | -0.008 | -0.009 | -0.007 | -0.015 |
| Weighted Avg Shares Out | 78,701 | 97,782 | 97,782 | 97,782 |
| Weighted Avg Shares Out Dil | 97,782 | 97,782 | 97,782 | 97,782 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $394 | $135 | $137 | $120 |
| Depreciation & Amortization | $165 | $164 | $164 | $164 |
| EBITDA | -$228 | -$348 | -$534 | -$1,147 |
| % Margin | -32% | -208.8% | -136.5% | -226.4% |